The value of conventional urine cytology in the diagnosis of residual tumour after transurethral resection of bladder carcinomas

Onkologie

Volumn 23, Issue 3, 2000, Pages 252-257

  Hakenberg, O W ^a   Franke, P ^b   Froehner, M ^b   Manseck, A ^b   Wirth, M P ^b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b NONE

Author keywords

Bladder neoplasms; Cytology; Sensitivity and specificity; Transurethral resection; Urine

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER CYTODIAGNOSIS; CANCER GRADING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; TRANSURETHRAL RESECTION; URINARY TRACT CARCINOMA; URINE CYTOLOGY;

EID: 0033909843     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000027140     Document Type: Article

References (19)

1. Ianari A, Sternberg CN, Rosetti A, Van Rijn A. Deidda A, Giannarelli D, Pansadoro V: Results of Bard BTA test in monitoring patients with a history of transitional cell cancer of the bladder. Urology 1997;49: 786-789.
2. Landmann J, Chang Y, Kavaler E, Droller MJ, Liu BC: Sensitivity and specificity of NMP-22, telomerase and BTA in the detection of human bladder cancer. Urology 1998;52:398-402.
3. Leyh H, Mazeman E: Bard BTA test compared with voided urine cytology in the diagnosis of recurrent bladder cancer. Eur Urol 1997;32:425-428.
4. Rübben H, Rathert P, Roth S, Hofstädter F, Giani G, Terhorst B, Friedrichs R: Exfoliative Urinyztologie. Harnwegstumorregister (4. Auf). Fort-und Weiterbildungskommission der Deutschen Urologen, Arbeits kreis Onkologie, Sektion Urinzytologie, Essen, 1989.
5. Jakse G, Hufnagel B, Hofstädter F, Rübben H: Sequentielle Blasenschleimhautbiopsie beim Urothelkarzinom der Harnblase. Verh Dtsch Ges Urol 1986;37:200.
6. Müller F, Kraft R, Zingg E: Exfoliative cytology after transurethral resection of superficial bladder tumours. Br J Urol 1985;57:530-532.
7. Roth S: Urinzytologische Arbeitstechniken: in Rathert P, Roth S (eds): Urinzytologie. Berlin, Springer, 1995. pp 61-82.
8. Papanicolaou GN, Marshall V: Urine sediment smears as diagnostic procedure in cancer of the urinary tract. Science 1945;101:500-520.
9. Colton T: Statistics in Medicine. (1st ed). Boston, Little, Brown and Company. 1974.
10. Lambl VD: Über Harnblasenkrebs. Ein Beitrag zur mikroskopischen Diagnostik am Krankenbett. Prager Vierteljahresschr Heilk 1856;49:1-32.
11. Sanders WR: Cancer of the bladder. Edinburgh Med J 1864;10:273-275.
12. Murphy WM: Diseases of the urinary bladder, urethra, ureters and renal pelves: in. Murphy WM (ed): Urological Pathology Philadelphia, W.B. Saunders. 1989, pp 34-146.
13. Murphy WM, Emerson LD, Chandler RW, Moinuddin SM, Soloway MS: Flow cytometry versus urinary cytology in the evaluation of patients with bladder cancer. J Urol 1986;136:815.
14. Esposti PL, Edsmyr B, Tribukait B: The role of exfoliative cytology in the management of bladder carcinoma. Urol Res 1978;6:197-201.
15. Schamhart DH, de Reijke TM, van der Poel HG, Witjes JA, de Boer EC, Kurth K, Schalken JA: The Bard BTA test: Its mode of action, sensitivity and specificity compared to cytology of voided urine in the diagnosis of superficial bladder cancer. Eur Urol 1998;34:99-106.
16. Del Nero A, Esposito N, Curro A, Biasoni D, M.B. Montanari E, Trinchieri A, Zanetti G, Serrago MP, Pisani E: Evaluation of urinary level of NMP-22 as a diagnostic marker for stage pTa-pT1 bladder cancer: Comparison with urinary cytology and BTA test. Eur Urol 1999;35:93-97.
17. Wiener HG, Vooijs GP, van't Hof-Groteboer B: Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer. Ada Cytol 1993;37: 163-169.
18. Jordan AM, Weingarten J, Murphy WM: Can biologic potential be predicted from histologie grading? Cancer 1987;60:2766-2767.
19. Badalament RA, Gay H, Cibas ES, Herr HW, Whitmore WF Jr, Fair WR, Melamed MR: Monitoring endoscopie treatment of superficial bladder carcinoma by postoperative urinary cytology. J Urol 1987;138:760-762.